Contributed Abstracts
Hall 1 (Salt Palace Convention Center)
Allogeneic Stem Cell Transplant for Children with Sickle Cell Disease Reduces Healthcare Utilization
Staci Arnold, MD, MBA, Columbia University Medical Center;
Zhezhen Jin, PhD, Columbia University;
Jacquelyn Bishop, BS, New York Presbyterian Hospital;
Monica Bhatia, MD, Columbia University;
Prakash Satwani, MD, Columbia University
Single Institution Experience with Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and AYA Patients with Acute Leukemia
Erin Breese, MD, PhD, Stanford University School of Medicine;
Rajni Agarwal, MD, Stanford University;
Sandhya Kharbanda, MD, Stanford University;
Marcus Breese, PhD, Indiana University School of Medicine;
Michael Amylon, MD, Stanford University Medical Center;
Kenneth I Weinberg, MD, Stanford University School of Medicine;
Matthew Porteus, MD, PhD, Stanford University;
Gary Dahl, MD, Stanford University School of Medicine;
Norman Lacayo, MD, Stanford University School of Medicine;
Krista Schlis, MD, Stanford University School of Medicine;
Jennifer Reikes Willert, MD, Stanford University School of Medicine
Alemtuzumab As Therapy for Mixed Chimerism After Hematopoietic Stem Cell Transplantation for Fanconi Anemia (FA)
Sharat Chandra, MD, Cincinnati Children's Hospital Medical Center;
Michael Grimley, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center;
Kasiani Myers, MD, Cincinnati Children's Hospital Medical Center;
Pooja Khandelwal, MD, Cincinnati Children's Hospital Medical Center;
Kejian Zhang, MD, MBA, Cincinnati Childrens Hospital Medical Center;
Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center
Hematopoietic Cell Transplant for Patients with NEMO Defect: A Single Center Experience
Shanmuganathan Chandrakasan, MD, Cincinnati Children's Hospital Medical Center;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Denise Bellman, Cincinnati Children's Hospital Medical Center;
Rebecca A Marsh, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center
Role of Conditioning Regimens in Pediatric Hematopoietic STEM CELL Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens
Surabhi Batra, MD, Ann & Robert H. Lurie Children's Hospital of Chicago;
Jennifer Schneiderman, Northwestern University Feinberg School of Medicine;
William T Tse, MD, PhD, Children's Memorial Research Center;
Reggie E Duerst, MD, Ann & Robert H. Lurie Children's Hospital of Chicago;
Morris Kletzel, MD, FAAP, MBA, Northwestern University Feinberg School of Medicine;
Sonali Chaudhury, Northwestern University Feinberg School of Medicine
Comprehensive Long Term Evaluation of End-Organ Function in Pediatric Patients Undergoing Matched Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease
Mari Hashitate Dallas, MD, St. Jude Children's Research Hospital;
David Shook, MD, St. Jude Children's Research Hospital;
Christine Mary Hartford, MD, St. Jude Childrens Research Hospital;
Ashok Srinivasan, MD, St.Jude Children's Research Hospital;
Brandon Matthew Triplett, MD, St Jude Childrens Research Hospital;
Wing Leung, MD, PhD, St. Jude Children's Research Hospital
Clinical Outcome of Allogeneic SCT with a RIC Regimen in Young Adults with AML in CR1; Impact of Prior Consolidation Therapy
Abhijeet Ganapule, MD, Christian Medical College;
Chepsy Phillip, MD, Christian Medical College;
Kavitha Lakshmi, MSc, Christian Medical College;
Biju George, MD, Christian Medical College;
Auro Viswabandya, MD, Christian Medical College;
Aby Abraham, MD, Christian Medical College;
Rayaz Ahmed, MD, Christian Medical College;
Alok Srivastava, MD, Christian Medical College;
Vikram Mathews, MD, Christian Medical College
Autologous Transplantation for Hodgkin disease: A Tale of Two Eras
Phillip M Garfin, MD PhD, Stanford University;
Sandra Luna-Fineman, MD, Stanford University;
Michael Amylon, MD, Stanford University Medical Center;
Sandhya Kharbanda, MD, Stanford University;
Kenneth I Weinberg, MD, Stanford University School of Medicine;
Jennifer Reikes Willert, MD, Rady Children's Hospital/Ucsd;
Matthew Porteus, MD, PhD, Stanford University;
Michael Link, MD, Stanford University;
Rajni Agarwal, MD, Stanford University
Donor Lymphocyte Infusions in Pediatric Patients with Malignant and Non-Malignant Diseases After Allogeneic Bone Marrow Transplantation: A Single Center Experience
Aharon Gefen, MD, MSc, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology;
Myriam Weyl-Ben-Arush, MD, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology;
Abdalla Khalil, MD, Rambam Medical Center;
Nira Arad-Cohen, MD, Rambam Medical Center;
Iris Porat, RN, Rambam Medical Center;
Irina Zaidman, MD, PhD, Rambam Medical Center
Bone Marrow Failure: Congenital Amegakaryocytic Thrombocytopenia- A Case Report of Successful Matched Unrelated Bone Marrow Transplantation in Pediatric Twins
Julia Gourde, RN, FNP, Mayo Clinic;
Preethi Marri, MD, Mayo Clinic;
Shakila P Khan, MD, Mayo Clinic;
Paul Galardy, MD, Mayo Clinic;
Amulya NageswaraRao, MBBS, Mayo Clinic;
Vilmarie Rodriguez, MD, Mayo Clinic
Assessment of Iron Overload in Pediatric Patients with Thalassemia Major During One Year Follow-up After Hematopoietic Stem Cell Transplantation Using T2* MRI Technique
Amir Ali Hamidieh, M.D., Tehran University of Medical Sciences;
Sirous Tayebi, Tehran University of Medical Sciences;
Maryam Behfar, M.D., Tehran University of Medical Sciences;
Ahmadreza Shamshiri, M.D., Tehran University of Medical Sciences;
Kamran Alimoghaddam, M.D., Tehran University of Medical Sciences;
Ardeshir Ghavamzadeh, M.D., Tehran University of Medical Sciences
Clinical Utility of Diagnostic Criteria for Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA): A Prospective Single Center Study
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Jane C Khoury, Cincinnati Children’s Hospital Medical Center;
Jens Goebel, MD, Cincinnati Children's Hospital Medical Center;
Matthew Zahner, Cincinnati Children's Hospital Medical Center;
Rebekah Kennedy, Cincinnati Children's Hospital Medical Center;
Teresa Kinsella, Cincinnati Children's Hospital;
Michael Grimley, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center;
Benjamin Laskin, MD, MS, Cincinnati Children's Hospital Medical Center, Cincinnati
Autologous Hematopoietic Cell Transplantation Can Prolong Life in High-Risk Neuroblastoma Patients in Partial Remission
Kimberly A Kasow, DO, University of North Carolina;
Cammie Moore Presler, RN, MSN, CPNP, University of North Carolina;
Andrew Sharf, RN, BS, University of North Carolina Hospitals;
Julie Blatt, MD, University of North Carolina
Case Series of Vaccine Associated Varicella Zoster Virus Infection in Immune Compromised Patients
Pooja Khandelwal, MD, Cincinnati Children's Hospital Medical Center;
Rebecca A Marsh, MD, Cincinnati Children's Hospital Medical Center;
D Scott Schmid, Ph D, Centers for Disease Control and Prevention;
Kay W Radford, BS, Centers for Disease Control and Prevention;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Michael Jordan, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center
Hematopoietic Cell Transplantation (HCT) for Treatment of Genetic Lymphohematopoietic Diseases for Patients Lacking a Fully Matched Sibling Donor Using a Novel Conditioning Regimen
Sandhya Kharbanda, MD, Stanford University;
Rajni Agarwal, MD, Stanford University;
David B. Miklos, MD, PhD, Stanford University Medical Center;
Matthew Porteus, MD, PhD, Stanford University;
Michael Amylon, MD, Stanford University Medical Center;
Jennifer R Willert, MD, Children's Hosp San Diego;
Kenneth I Weinberg, MD, Stanford University School of Medicine
Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia
Jennifer Krajewski, MD, Hackensack University Medical Center;
Kavita Radhakrishnan, New York Medical College;
Nan Chen, BS, New York Medical College;
Angela Ricci, New York Medical College;
Mark Geyer, AB, Massachusetts General Hospital, Harvard Medical School;
Lauren Harrison, RN, New York Medical College;
M Fevzi Ozkaynak, MD, New York Medical College;
Prakash Satwani, MD, Columbia University;
Alexandra Cheerva, MD, MS, University of Louisville;
Julie-An Talano, MD, Children's Hospital of Wisconsin;
Theodore B Moore, MD, David Geffen School of Medicine at UCLA;
Alfred P. Gillio, HUMC;
Lee Ann Baxter-Lowe, PhD, UCSF;
Mitchell S. Cairo, MD, New York Medical College
Persistent BK Virus Viremia (pBKV) and Kidney Injury At Day 100 After Pediatric Allogeneic Hematopoietic Stem Cell Transplant (SCT)
Benjamin Laskin, MD, MS, The Children's Hospital of Philadelphia;
Susan Furth, MD, PhD, The Children's Hospital of Philadelphia;
Rebecca Ruebner, MD, MSCE, The Children's Hospital of Philadelphia;
Matthew Zahner, Cincinnati Children's Hospital Medical Center;
Jens Goebel, MD, Cincinnati Children's Hospital Medical Center;
Gretchen Radloff, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center
Reduced Intensity Hematopoietic Cell Transplantation for Non-Fanconi Anemia Marrow Failure Syndromes
Parinda A Mehta, MD, Cincinnati Children's Hospital Medical Center;
Rebecca A Marsh, MD, Cincinnati Children's Hospital Medical Center;
Mi-Ok Kim, Cincinnati Children's Hospital Medical Center;
Kasiani Myers, MD, Cincinnati Children's Hospital Medical Center;
Denise Bellman, Cincinnati Children's Hospital Medical Center;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Sharat Chandra, MD, Cincinnati Children's Hospital Medical Center;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center;
Michael Grimley, MD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Michael Jordan, MD, Cincinnati Children's Hospital Medical Center;
Ashish Kumar, MD, PhD, Cincinnati Children's Hospital Medical Center;
Michelle Harris, Cincinnati Children's Hospital Medical Center;
Kathleen Ball, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center
Autologous Stem Cell Collection for the Treatment of Malignant Diseases in Pediatric Patients: The Use of the Power Hickman
Mollie Mulberry, RN, MS, CPNP, Medical College of Wisconsin;
David Margolis, MD, Medicial College of Wisconsin;
Rowena C. Punzalan, MD, Blood Center of Wisconsin;
Michael Kelly, MD, Medical College of Wisconsin;
Meghen Browning, MD, Medical College of Wisconsin
Outcomes After Second Allogeneic Transplants in Pediatric Patients with Relapsed Hematological Malignancies
Swati Naik, Baylor College of Medicine, Texas Children's Hospital;
Caridad Martinez, MD, Baylor College of Medicine, Texas Children's Hospital;
Catherine M. Bollard, MD, Baylor College of Medicine, Texas Children's Hospital;
Javier Amin El-Bietar, MD, Baylor College of Medicine, Texas Children's Hospital;
Stephen Gottschalk, MD, Baylor College of Medicine, Texas Children's Hospital;
Kathryn Leung, MD, Baylor College of Medicine, Texas Children's Hospital;
Carl Allen, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Nabil M Ahmed, MD, MPH, Baylor College of Medicine, Texas Children's Hospital;
Helen E Heslop, MD, Baylor College of Medicine, Texas Children's Hospital;
Malcolm K. Brenner, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Robert A. Krance, MD, Baylor College of Medicine, Texas Children's Hospital
Outcomes in Pediatric Patients with Engraftment Failure After Allogeneic Transplants
Swati Naik, Baylor College of Medicine, Texas Children's Hospital;
Caridad Martinez, MD, Baylor College of Medicine, Texas Children's Hospital;
Catherine M. Bollard, MD, Baylor College of Medicine, Texas Children's Hospital;
Javier Amin El-Bietar, MD, Baylor College of Medicine, Texas Children's Hospital;
Stephen Gottschalk, MD, Baylor College of Medicine, Texas Children's Hospital;
Kathryn Leung, MD, Baylor College of Medicine, Texas Children's Hospital;
Nabil M Ahmed, MD, MPH, Baylor College of Medicine, Texas Children's Hospital;
Carl Allen, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Helen E Heslop, MD, Baylor College of Medicine, Texas Children's Hospital;
Malcolm K. Brenner, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Robert A. Krance, MD, Baylor College of Medicine, Texas Children's Hospital
Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels At the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention
Brandon Nuechterlein, MPAS, Unviersity of Colorado;
Tracey Duncan, University of Colorado;
Angela Peltz, MPAS, The Children's Hospital/University of Colorado;
Kelly Drake, university of colorado;
Janet Bathurst, The Children's Hospital;
Michele Finnerty, Childrens Hospital Colorado;
Amy Keating, MD, The Childrens Hospital;
John Craddock, MD, University of Colorado;
Suzzanne Smolik, univeristy of colorado;
Ralph Quinones, MD, The Children's Hospital;
Roger Giller, MD, The Children's Hospital, Denver, University of Colorado School of Medicine
The Risk Factors Associated with Liver Injury and the Impact of Liver Injury On Transplant Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Kavita Radhakrishnan, Yale Medical school;
Jacquelyn Bishop, BS, New York Presbyterian Hospital;
Zhezhen Jin, PhD, Columbia University;
Komal Kothari, BS, Columbia University, NY;
Monica Bhatia, MD, Columbia University;
Diane George, MD, Children's Hospital of New York;
James Garvin, MD, PhD, Columbia University/New York-Presbyterian Hospital;
Mercedes Martinez, MD, Columbia University, NY;
Nadia Ovchinsky, MD, Columbia University, NY;
Steven Lobritto, Columbia University, NY;
Yasmin Elsayed, MS, Columbia University;
Prakash Satwani, MD, Columbia University
CNS Disease At Diagnosis May Predict Relapse of Hematologic Malignancies in Pediatric Patients After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
Nirali Shah, MD, National Cancer Institute/National Institutes of Health;
Michael J Borowitz, MD, PhD, Johns Hopkins Hospital;
Seth Steinberg, PhD, Center for Cancer Research, National Cancer Institute, National Institutes of Health;
Nancy Robey, PA, Johns Hopkins Hospital;
Christopher Gamper, MD, PhD, Johns Hopkins Hospital;
Heather Symons, MD, Johns Hopkins Hospital;
David Loeb, MD, PhD, Johns Hopkins Hospital;
Alan S Wayne, MD, National Cancer Institute/National Institutes of Health;
Allen Chen, MD, PhD, MHS, Johns Hopkins Hospital
Recovery of Lymphocyte Function May Predict Risk of Leukemic Relapse in Pediatric Patients Undergoing Allogeneic Stem Cell Transplant
Justin T Wahlstrom, M.D., UCSF Benioff Children's Hospital;
Patricia Murphy, RN, MSN, UCSF Children's Hospital;
Biljana Horn, MD, UCSF Benioff Children's Hospital;
Morton J Cowan, MD, UCSF Benioff Children's Hospital;
Christopher C Dvorak, MD, UCSF Benioff Children's Hospital
![[Visit Client Website]](images/banner.gif)